Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate

Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate

US Patent 8288342 · Granted Oct 16, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oral eliglustat transmucosal delivery system2023
Long acting injectable formulations2023
Oral eliglustat transmucosal delivery system2022
Monolithic intravaginal rings comprising progesterone and methods of making and 2022
Oral transmucosal drug delivery system2020
Monolithic intravaginal rings comprising progesterone and methods of making and 2020
Monolithic intravaginal rings comprising progesterone and methods of making and 2020
Oral transmucosal drug delivery system2017
Oral transmucosal drug delivery system2016
Extended-release oral dosage forms for poorly soluble amine drugs2015
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatolog2014
Oral dosage forms comprising progesterone and methods of making and using the sa2014